Results 131 to 138 of about 33,811 (138)

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Cell Reports, 2020
Andrea J Pruijssers, Amelia S George, Sarah R Leist   +2 more
exaly  

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

Lancet, The, 2022
exaly  

Remdesivir against COVID-19 and Other Viral Diseases

Clinical Microbiology Reviews, 2020
Jakob J Malin, Isabelle Suárez, Priv-Doz Dr Dr Jan Rybniker   +2 more
exaly  

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Proceedings of the National Academy of Sciences of the United States of America, 2020
Emmie de Wit, Friederike Feldmann, Jacqueline Cronin   +2 more
exaly  

Hints of hope with remdesivir

Nature Reviews Drug Discovery, 2020
exaly  

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

Lancet Respiratory Medicine,the, 2023
exaly  

Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir

Viruses, 2019
Joy Y Feng, Danielle P Porter, Matthias Götte   +2 more
exaly  

Remdesivir for COVID-19: challenges of underpowered studies

Lancet, The, 2020
exaly